Advertisement
Screener

Celldex Therapeutics, Inc. (CLDX) Analyst Insights

RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$29.91(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$29.91High(m)Average(m)Low(m)2025-11-062026-11-06
DateStockAnalystFirmPrice When RatedPrice TargetUpside / DownsideRatingPerformance
2026-08-06CLDX
Celldex Therapeutics, Inc.
Etzer Darout, PhD, MBABarclays$41.56$53.00+27.53%Overweight
2026-05-07CLDX
Celldex Therapeutics, Inc.
Etzer Darout, PhD, MBABarclays$33.32$48.00+44.06%Overweight
2026-04-20CLDX
Celldex Therapeutics, Inc.
Etzer Darout, PhD, MBABarclays$34.55$45.00+30.25%Overweight
2025-12-17CLDX
Celldex Therapeutics, Inc.
Etzer Darout, PhD, MBABarclays$27.09$24.00-11.41%Underweight
2025-11-11CLDX
Celldex Therapeutics, Inc.
Etzer Darout, PhD, MBABarclays$22.67$21.00-7.37%Underweight
2025-10-13CLDX
Celldex Therapeutics, Inc.
Etzer Darout, PhD, MBABarclays$26.77$25.00-6.61%Underweight

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93